Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cellsMoiez Ali, Kris C. Wood, Min Lu et al.|Science Translational Medicine|2022Cited by 45
P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemiaKevin Lin, Kris C. Wood, Zhecheng Sheng et al.|Nature Cancer|2022Cited by 42
The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting TherapiesAngela Su, Alexandre Puissant, Frank Ling et al.|Cancer Discovery|2020Cited by 26
Integrative <i>PTEN</i> Enhancer Discovery Reveals a New Model of Enhancer OrganizationChristian Cerda-Smith, Kris C. Wood, Haley M. Hutchinson et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 5
The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting TherapiesAngela Su, Alexandre Puissant, Frank Ling et al.|Blood|2019Cited by 5